Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Activity To Improve Outcomes in Peripheral Arterial Disease (ACTION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02189018
Recruitment Status : Enrolling by invitation
First Posted : July 14, 2014
Last Update Posted : July 8, 2020
Sponsor:
Information provided by (Responsible Party):
Brajesh K Lal, Baltimore VA Medical Center

Brief Summary:
Peripheral artery disease (PAD) results in blockages of arteries (blood vessels) in the legs and decreased blood flow to the legs. This may cause difficulty or pain with walking or other activities that use leg muscles. Exercise may help improve blood flow in the legs and improve the ability to walk. This research project is being implemented in adults with PAD to examine the effects of exercise or weight loss programs on lower extremity blood flow, health, and physical function.

Condition or disease Intervention/treatment Phase
Peripheral Arterial Occlusive Disease Other: Active Exercise Other: Neuromuscular electrical stimulation Other: Weight loss and active exercise Other: Ad lib activity at home Not Applicable

Detailed Description:

This pilot study seeks to gather data on different exercise interventions in PAD. Collectively, the proposed studies will gather data on the role of novel exercise interventions in those with PAD who are receiving conservative treatment as well as those who have undergone an endovascular intervention for lower extremity arterial disease.

We hypothesize that patients who undergo an exercise intervention will: A) show improved lower extremity perfusion and B) improve their functional ability, compared to a standard care control group over 6 months of follow-up. We further hypothesize that these improvements are mediated through angiogenesis and increased perfusion of the lower limb, as well as improvements in muscle strength, mass, and function.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Activity To Improve Outcomes in Peripheral Arterial Disease
Actual Study Start Date : August 2014
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : August 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Control
Ad lib activity at home
Other: Ad lib activity at home
Ad lib activity at home

Experimental: Active Exercise
Active exercise on treadmill
Other: Active Exercise
Active exercise on a treadmill

Experimental: Neuromuscular electrical stimulation
Neuromuscular electrical stimulation
Other: Neuromuscular electrical stimulation
Neuromuscular electrical stimulation

Experimental: Weight loss and active exercise
Weight loss plus active exercise on treadmill
Other: Weight loss and active exercise
Weight loss and active exercise on a treadmill




Primary Outcome Measures :
  1. Lower extremity perfusion [ Time Frame: 6 months ]
    Ankle brachial index and ultrasound quantification of muscle perfusion


Secondary Outcome Measures :
  1. Functional capacity [ Time Frame: 6 months ]
    Treadmill exercise testing



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 21-90 years
  • Ankle brachial index < 0.9

Exclusion Criteria:

  • Cancer under active treatment, except prostate, skin, and hematologic cancers
  • Planned for open lower extremity bypass surgery
  • Body mass index >45
  • Lower extremity gangrene

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02189018


Locations
Layout table for location information
United States, Maryland
Baltimore VAMC
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
Baltimore VA Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Brajesh K Lal, MD Baltimore VAMC, University of Maryland School of Medicine
Layout table for additonal information
Responsible Party: Brajesh K Lal, Professor, Baltimore VA Medical Center
ClinicalTrials.gov Identifier: NCT02189018    
Other Study ID Numbers: HP-00059151
First Posted: July 14, 2014    Key Record Dates
Last Update Posted: July 8, 2020
Last Verified: July 2020
Keywords provided by Brajesh K Lal, Baltimore VA Medical Center:
Peripheral arterial disease
Endovascular
Exercise
Perfusion
Functional capacity
Additional relevant MeSH terms:
Layout table for MeSH terms
Peripheral Arterial Disease
Peripheral Vascular Diseases
Arterial Occlusive Diseases
Atherosclerosis
Arteriosclerosis
Vascular Diseases
Cardiovascular Diseases